2026 Exclusive Full DRUG LIST (Formulary)
Capital Blue Cross Exclusive Full Formulary listing covered prescription drugs, tier placement, specialty designation, and utilization management indicators (prior authorization, step therapy, quantity limits, limited distribution) for fully insured individual and employer group plans in Pennsylvania.
No material clinical or coverage changes noted in this brief (has_material_change=false).
Coverage Summary
General Formulary Coverage Criteria
This fragment of the Capital Blue Cross 2026 Exclusive Full Drug List (Formulary) summarizes the formulary coverage stance and scope for the plan. It describes what the formulary covers and the plan-level boundaries for covered prescription drugs.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.